Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

CRISPR/Cas technology, originally derived from the adaptive immune systems of bacteria and archaea, has revolutionized biomedical research. By utilizing a guide RNA (gRNA) to direct a Cas nuclease to a specific genomic location, researchers can induce double-stranded breaks or perform precise base editing. This capability has moved beyond simple DNA disruption to include transcriptional regulation, epigenome editing, and high-throughput screening. The recent FDA approval of CRISPR-based therapies for sickle cell anemia marks a significant milestone, signaling a transition from experimental research to clinical reality.

The versatility of CRISPR/Cas is evident in its wide range of applications. In oncology, CRISPR is used to identify cancer dependencies, silence oncogenes, and enhance the efficacy of CAR T-cell therapies by removing negative regulators or inserting therapeutic genes. Beyond cancer, the technology is being explored for hereditary conditions such as cystic fibrosis, hemophilia, and various liver diseases. Furthermore, CRISPR/Cas has proven effective in targeting viral pathogens, including HIV, by excising proviral DNA from infected cells, offering a potential path toward a sterilizing cure.

A major hurdle for clinical translation is the effective delivery of CRISPR components into diseased cells. While viral vectors like AAV and lentivirus are commonly used, their packaging capacity and immunogenicity pose challenges. The development of ultra-compact Cas variants, such as Cas12f, allows for easier packaging into AAV vectors, facilitating in vivo applications. Additionally, non-viral delivery methods like lipid nanoparticles (LNPs) are gaining traction due to their high biocompatibility. In vaccine development, CRISPR/Cas is used to engineer viral vectors and B-cells, enabling the production of multivalent, highly potent vaccines that are more efficient and cost-effective than traditional methods.